Thyrocare Technologies Limited (NSE:THYROCARE)

Thyrocare Technologies Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Operating Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	1,442	1,630	915.1	707.6	644.9	1,761
Depreciation & Amortization	611.9	581	547.3	465.6	380.2	338.7
Other Amortization	4.8	4.8	5.3	4.5	6.9	-
Loss (Gain) From Sale of Assets	-31.9	-40.9	-0.1	9.3	-4.3	-213.4
Loss (Gain) From Sale of Investments	-84.7	-77.1	-88.1	-57.9	-53.7	-52.2
Stock-Based Compensation	236.8	240.9	245.1	166.7	211.7	23.2
Provision & Write-off of Bad Debts	-21.5	-18.7	12.6	88.3	95.2	102
Other Operating Activities	284.5	-103.4	50.6	-9.4	-45.7	-33.4
Change in Accounts Receivable	-136.8	-9.9	-307.9	328.2	-14.3	-587.2
Change in Inventory	-108.1	-19.2	9.9	-198.5	-31.4	-11.7
Change in Accounts Payable	-33	-108.6	361	161.2	74.2	-84.8
Change in Other Net Operating Assets	25.4	53.1	48.3	10.7	29.4	-108.5
Operating Cash Flow	2,189	2,132	1,799	1,676	1,293	1,134
Operating Cash Flow Growth	-4.54%	18.53%	7.33%	29.63%	14.02%	-1.15%

Investing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Capital Expenditures	-382.9	-208.8	-334.8	-615.8	-436.5	-378.3
Sale of Property, Plant & Equipment	45	54	0.1	7.2	21	229.3
Cash Acquisitions	-	-	-112.6	-	-	-
Divestitures	-	-	-	-	-	42.5
Investment in Securities	-271.5	-106	16.5	-314	12.6	-136.5
Other Investing Activities	28.3	30.7	19.7	9.7	13	7.3
Investing Cash Flow	-581.1	-230.1	-411.1	-912.9	-389.9	-235.7

Financing Activities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Long-Term Debt Issued	-	-	-	286.2	-	-
Long-Term Debt Repaid	-	-183.9	-320.8	-127.5	-55.3	-53.8
Lease Payments	-175.3	-183.9	-104.9	-57.2	-55.3	-53.8
Net Debt Issued (Repaid)	-175.3	-183.9	-320.8	158.7	-55.3	-53.8
Issuance of Common Stock	-	-	0.4	0.2	0.3	0.3
Repurchase of Common Stock	-0.1	-	-	-	-	-
Common Dividends Paid	-1,486	-1,484	-953.1	-952.7	-793.5	-793.1
Other Financing Activities	-43.2	-27.7	-30.7	-54.3	-13.3	-47.5
Financing Cash Flow	-1,705	-1,696	-1,304	-848.1	-861.8	-894.1

Net Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Cash Flow	-96.4	206.4	83.8	-84.7	41.4	4.3

Free Cash Flow

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Free Cash Flow	1,807	1,924	1,464	1,061	856.6	755.8
Free Cash Flow Growth	2.37%	31.37%	38.08%	23.80%	13.34%	-14.15%
Free Cash Flow Margin	19.42%	23.20%	21.30%	18.54%	16.26%	12.83%
Free Cash Flow Per Share	11.22	12.05	9.18	6.67	5.39	4.75
Levered Free Cash Flow	1,423	1,719	1,218	582.04	748.3	815.46
Unlevered Free Cash Flow	1,450	1,737	1,237	608.29	762.99	830.28
Free Cash Flow After Leases	1,631	1,740	1,359	1,003	801.3	702

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash Interest Paid	43.2	27.7	30.7	66.4	22.5	47.5
Cash Income Tax Paid	743.2	598.2	513.8	289.9	284.6	567.6
Change in Working Capital	-252.5	-84.6	111.3	301.6	57.9	-792.2

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 9, 2026

Data Sources Report a data error